Prestige Consumer Healthcare (PBH) Competitors $82.36 -0.43 (-0.52%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends PBH vs. IPAR, HLF, USNA, NUS, NATR, MED, VERU, EL, SMMT, and RPRXShould you be buying Prestige Consumer Healthcare stock or one of its competitors? The main competitors of Prestige Consumer Healthcare include Inter Parfums (IPAR), Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Veru (VERU), Estée Lauder Companies (EL), Summit Therapeutics (SMMT), and Royalty Pharma (RPRX). Prestige Consumer Healthcare vs. Inter Parfums Herbalife USANA Health Sciences Nu Skin Enterprises Nature's Sunshine Products Medifast Veru Estée Lauder Companies Summit Therapeutics Royalty Pharma Prestige Consumer Healthcare (NYSE:PBH) and Inter Parfums (NASDAQ:IPAR) are both mid-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, community ranking, analyst recommendations, profitability, media sentiment, valuation, institutional ownership, earnings and dividends. Do institutionals and insiders hold more shares of PBH or IPAR? 100.0% of Prestige Consumer Healthcare shares are owned by institutional investors. Comparatively, 55.6% of Inter Parfums shares are owned by institutional investors. 1.6% of Prestige Consumer Healthcare shares are owned by company insiders. Comparatively, 43.9% of Inter Parfums shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media refer more to PBH or IPAR? In the previous week, Inter Parfums had 16 more articles in the media than Prestige Consumer Healthcare. MarketBeat recorded 35 mentions for Inter Parfums and 19 mentions for Prestige Consumer Healthcare. Prestige Consumer Healthcare's average media sentiment score of 0.51 beat Inter Parfums' score of 0.33 indicating that Prestige Consumer Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Prestige Consumer Healthcare 6 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Inter Parfums 9 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer PBH or IPAR? Prestige Consumer Healthcare currently has a consensus target price of $83.67, indicating a potential upside of 1.59%. Inter Parfums has a consensus target price of $157.50, indicating a potential upside of 26.35%. Given Inter Parfums' stronger consensus rating and higher possible upside, analysts clearly believe Inter Parfums is more favorable than Prestige Consumer Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Prestige Consumer Healthcare 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Inter Parfums 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility and risk, PBH or IPAR? Prestige Consumer Healthcare has a beta of 0.47, indicating that its share price is 53% less volatile than the S&P 500. Comparatively, Inter Parfums has a beta of 1.16, indicating that its share price is 16% more volatile than the S&P 500. Is PBH or IPAR more profitable? Prestige Consumer Healthcare has a net margin of 18.54% compared to Inter Parfums' net margin of 10.60%. Inter Parfums' return on equity of 16.34% beat Prestige Consumer Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Prestige Consumer Healthcare18.54% 12.23% 6.14% Inter Parfums 10.60%16.34%10.82% Which has higher valuation and earnings, PBH or IPAR? Prestige Consumer Healthcare has higher earnings, but lower revenue than Inter Parfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Inter Parfums, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrestige Consumer Healthcare$1.13B3.62$209.34M$4.1120.04Inter Parfums$1.42B2.81$152.65M$4.6626.75 Does the MarketBeat Community favor PBH or IPAR? Prestige Consumer Healthcare received 30 more outperform votes than Inter Parfums when rated by MarketBeat users. Likewise, 70.77% of users gave Prestige Consumer Healthcare an outperform vote while only 64.65% of users gave Inter Parfums an outperform vote. CompanyUnderperformOutperformPrestige Consumer HealthcareOutperform Votes48970.77% Underperform Votes20229.23% Inter ParfumsOutperform Votes45964.65% Underperform Votes25135.35% SummaryInter Parfums beats Prestige Consumer Healthcare on 11 of the 18 factors compared between the two stocks. Ad ReticulateThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t Get Prestige Consumer Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PBH vs. The Competition Export to ExcelMetricPrestige Consumer HealthcarePharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$4.07B$6.39B$5.06B$19.82BDividend YieldN/A8.04%5.06%3.50%P/E Ratio20.0410.0598.3441.68Price / Sales3.62266.591,206.1919.76Price / Cash16.5353.4940.6921.65Price / Book2.359.306.324.66Net Income$209.34M$154.14M$119.47M$983.45M7 Day Performance2.48%-9.49%-5.11%-2.12%1 Month Performance14.52%-7.23%-3.20%-0.47%1 Year Performance39.57%30.70%32.42%24.69% Prestige Consumer Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PBHPrestige Consumer Healthcare3.3127 of 5 stars$82.36-0.5%$83.67+1.6%+40.7%$4.07B$1.13B20.04540Insider SellingAnalyst RevisionIPARInter Parfums4.4218 of 5 stars$127.25-1.2%N/A-3.9%$4.08B$1.42B27.31530Analyst ForecastShort Interest ↑Analyst RevisionNews CoverageHLFHerbalife4.185 of 5 stars$8.36-3.6%N/A-39.7%$842.62M$5.00B9.849,200USNAUSANA Health Sciences2.8525 of 5 stars$40.84-1.1%N/A-13.2%$778.41M$861.97M14.431,800NUSNu Skin Enterprises3.9986 of 5 stars$7.18-0.6%N/A-58.4%$356.86M$1.78B-3.473,700NATRNature's Sunshine Products2.9451 of 5 stars$16.85-3.3%N/A-7.6%$311.89M$445.32M19.15814Positive NewsMEDMedifast2.5715 of 5 stars$19.28-0.8%N/A-73.5%$210.89M$674.48M29.21870Positive NewsVERUVeru2.661 of 5 stars$0.67-7.2%N/A-44.9%$98.09M$16.30M-1.40189Positive NewsELEstée Lauder Companies4.8849 of 5 stars$62.50-3.2%N/A-49.4%$22.44B$15.61B111.6162,000Short Interest ↑SMMTSummit Therapeutics2.1774 of 5 stars$21.91+0.6%N/A+824.7%$16.16B$700,000.00-78.25105Gap UpRPRXRoyalty Pharma4.7875 of 5 stars$25.97-1.5%N/A-4.9%$15.41B$2.36B13.4680Positive News Related Companies and Tools Related Companies IPAR Competitors HLF Competitors USNA Competitors NUS Competitors NATR Competitors MED Competitors VERU Competitors EL Competitors SMMT Competitors RPRX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:PBH) was last updated on 11/16/2024 by MarketBeat.com Staff From Our PartnersThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this BEFORE November 19th.Brownstone Research | Sponsored🗓️ My First LIVE Event in 5 Years!Give us 60 minutes and we’ll show you how we’ve compressed 15 years of stock market gains into one day.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prestige Consumer Healthcare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Prestige Consumer Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PBH Stock Alerts